Preethi Sundaram, Ph.D., has been Catalyst’s Chief Strategy Officer since 2022. Previously, Dr. Sundaram served as the company’s Chief Product Development Officer. As of December 2024, Dr. Sundaram was appointed as a member of the board of directors of Cilcare. Dr. Sundaram has more than 25 years’ experience managing and mentoring teams delivering lifesaving medicines to patients. Prior to Catalyst, Dr. Sundaram was employed with Sanofi, including as Global Clinical Research Director, International Development, Global Project Head, Multiple Therapeutic Area Programs, Global Head and VP, Medical Operations, Primary Care Business Unit, and as Sanofi’s Global Head and VP, Medical Operations, General Medicines Business Unit. In that last position, Dr. Sundaram was accountable for leadership of critical global medical operational functions, including the oversight of portfolio financials and delivery of strategic milestones, and being responsible for the leadership of multiple portfolio management functions across all therapeutic areas in Sanofi’s Medicines Business Unit. Dr. Sundaram holds a Bachelor of Arts in Psychology from the University of Madras, a Bachelor of Science in Optometry from the Elite School of Optometry & Bits, a Doctor of Philosophy in Optometry from Anglia Ruskin University, and an Executive Business Masters from the London Business School.